New Center for Psychoanalysis

Healing Affects in Clinical Practice Series

Restructuring Defenses: IS-TDP Overview for Advanced Clinicians

Instructor: Thomas M. Brod, MD

4 Sessions, 8 hours

Mondays, Oct. 30, Nov. 5, 12, 19, 2007 7:45-9:45 pm

Course Description

The Healing Affects Series derives from the ground-breaking work of Habib Davanloo, M.D. on affect and attachment.  In prior years, the Series has examined such practical clinical topics as working with anxiety, depression, regressive reactions, and explosive discharge and outbursts.

This course will overview the revolutionary technical advances Davanloo brought to psychoanalytic therapy to bring about rapid, potent (long-lasting) symptom relief utililizing transference-based dynamic interventions.  The course will highlight the relationship between character structure, resistance, and the unconscious therapeutic alliance.   Videotape vignettes will be used throughout the course.

Since this course is intended for advanced licensed clinicians, permission of the instructor is required for non-psychoanalysts prior to registration for this course.

Objectives: At the end of this course, participants should be able to

1. Discuss the relationship of time-sensitive preessure in the management of character resistances;

2. Assess and manage anxiety in a wide-range of psychopathology;

3. Discuss the management of the moral emotions, shame and guilt, in IS-TDP treatment;

4. Effectively and safely multiple affective elements of IS-TDP technique in their own clinical practice.

Thomas M Brod, MD, is faculty the New Center for Psychoanalysis, Associate Clinical Professor of Psychiatry, UCLA, and in private practice in west Los Angeles.

 

---

 

American Psychiatric Association
160th Annual Meeting, San Diego, California
Course # C085
EEG Feedback in Psychiatry: Clinical Applications

DATE SCHEDULED: Wednesday, May 23, 2007, 9:00 AM -Wednesday, May 23, 2007, 4:00 PM
LOCATION: Ford Room A/B/C, Third Level, Manchester Grand Hyatt
Director: Thomas M. Brod, M.D.
Course Description:
EEG biofeedback (Neurofeedback) uses computer-based technology to affect brain plasticity and accelerate positive clinical outcomes. How do you “train the brain” with EEG biofeedback to improve affect, attention and behavior? How do you train neuroregulation and neuromodulation by altering electroencephalographic patterns-- and what are the clinical implications? How can neurofeedback (EEG biofeedback) be integrated into the practice of a reasonably tech-savvy psychiatrist?
Neurofeedback demonstrates the impact of information on the brain, creating functional (and, most likely, structural) changes that impact clinical syndromes.
Beyond well-known effects on arousal and attention mechanisms and its role in the treatment of ADHD, growing research publications and clinical experience have led to the application of neurofeedback in a wide range of disorders. With applications as disparate as mood and anxiety disorders, Tourette’s syndrome, epilepsy, post-traumatic brain injuries, attachment disorders, PTSD, substance abuse, and adolescent acting out, neurofeedback mirrors the scope of many general psychiatric practices. Neurofeedback is complementary to both psychopharmacology and dynamic psychotherapy.
This course will focus on a few of those applications and offer resources for further study. Current research will be critically reviewed, and some of the fascinating theoretical issues of brain self-regulation and plasticity will be noted, but essentially this six-hour course will be directed with an eye on practical issues.
Attendees also get to watch (or participate) in live demonstrations of several different available neurofeedback systems. Faculty are practitioners from several centers invited because of their exceptional teaching ability.

EEG Neurofeedback in Psychiatry: Clinical Applications
9:00 AM
Introduction/Applications (Brod)
9:25
EEG basics (Buie)
9:45
Live demo of neurofeedback (w/Audience)
10:00
Break
10:15
Case Examples (Schummer)
10:30
Audience discussion
10:40
NF Research Review including critique (Burke)
11:10
Audience discussion
11:20
How is NF used in a Psychiatric Practice (Panel)
11:40
Substance Abuse (Scott)-
12:00 PM
Lunch
1:00
Audience discussion
1:10
Attention Disorders: (Schummer,)
1:35
Bipolar disorder (Buie)
1:55
Head Injury (Burke)
2:15
Panel w/audience discussion
2:35
Break
2:50
Diversity in the NF field (Demos)
3:20
Panel discussion w/Audience
3:50
Closing: evals

American Psychiatric Association
160th Annual Meeting, San Diego, California
Symposium # 42

Psilocybin and Psychiatry: Recent Research

Tuesday, May 22, 2007, 2:00 PM - 5:00 PM

Session Leader:
Thomas M Brod, MD

UCLA David Geffen School of Medicine, Dept. of Psychiatry and Biobehavioral Science

SUMMARY:
Although psilocybin has been used for centuries for religious purposes, relatively little is known scientifically about its acute and persisting effects. A naturally occurring tryptamine alkaloid with actions mediated primarily at serotonin 5-HT2A/C receptor sites, it has been long-used ceremonially in diverse cultures for spiritual/healing purposes. The psychological effects of psilocybin are similar to other serotonergically mediated hallucinogens. Early clinical research with psilocybin attempted to study the effects of psilocybin without recognition of the powerful influences of set and setting. Subsequent research, accommodating those influences, found fewer adverse psychological effects, and increased reports of positively valued experiences. In response to the epidemic of hallucinogen abuse that occurred in the 1960s, clinical research largely ceased and has resumed only recently.
This symposium will present recent psilocybin research studies by investigators from three US centers. Charles S. Grob, MD will examine the rationale, historical foundation and recent research using the hallucinogen treatment model with advanced-stage cancer patients with anxiety. Francisco Moreno, MD will report on his modified double-blind study evaluating the safety, tolerability, and clinical effects of psilocybin on symptoms of Obsessive Compulsive Disorder (OCD). Roland Griffiths, PhD will review and provide 14 month follow-up to last year’s ground-breaking study, on psilocybin and mystical-type experiences. That study (Griffiths, et al, Psychopharmacology 187:268-283, 2006) was published with five laudatory reviewer and editorial commentaries, including the following by DE Nichols: “It is the first well-designed, placebo controlled, clinical study in more than four decades to examine the psychological consequences of [psilocybin].... Perhaps more importantly, the present study convincingly demonstrates that, when used appropriately, these compounds can produce remarkable, possibly beneficial, effects that deserve further study.”
This symposium will conclude with a discussion with the audience exploring the further research challenges in the scientific study of hallucinogenic (psychedelic) drugs.

Healing Affects in Clinical Practice: Shame and Guilt
http://www.n-c-p.org/Extension_Division/psychoanalysis.courses.F06.healingaffects.htm

The Reflective Clinician Series

and

Southern California Psychiatric Society

Co-Sponsor

Encounters at the Extreme: An End-of-Life Care Workshop

Saturday, July 22, 2006, 9:00 AM – 1:15 PM

Location: NCP auditorium, 2014 Sawtelle Blvd. 310.478-6541
CE Units: 4 Fee: $75 (pre-register); $90 at the door

This 4 hr structured workshop is designed for physicians and mental health care givers interested
in dealing sensitively with terminal care from the perspective of dying people, their families, and
care-giving systems.

The program will be include didactic lectures, discussion with audience and structured
conversations in small groups.

The Reflective Clinician series satisfies 4 hours of the requirement of the Medical Board of
California as a CME course on pain and terminal care. Organized to meet the needs of
physicians of all specialties, psychotherapists and other care-givers are welcome to participate.

[more info]

Location: New Center For Psychoanalysis (formerly LAPSI) Auditorium 2014 Sawtelle Blvd, W Los Angeles

Date: Saturday October 29, 2005 (6 hrs)
Location: Museum of Contemporary Art (MOCA) Auditorium
250 South Grand Avenue,Los Angeles, CA 90012

Co-Sponsored with MOCA by New Center for Psychoanalysis and
the C.G. Jung Institute of Los Angeles